Abstract
Nanotechnology has emerged as an important interdisciplinary field in modern medicine, particularly in drug delivery, diagnosis, cancer treatment, gene therapy, vaccine development, regenerative medicine, and personalized healthcare. Conventional drug-delivery systems frequently encounter limitations such as poor aqueous solubility, rapid degradation, short circulation time, nonspecific distribution, low bioavailability, and systemic toxicity. Nanotechnology provides strategies for addressing several of these limitations by engineering materials and carriers at the nanoscale. Liposomes, polymeric nanoparticles, lipid nanoparticles, dendrimers, micelles, nanogels, inorganic nanoparticles, and hybrid nanocarriers can be designed to transport therapeutic molecules and release them in a controlled manner. Nanocarriers may improve drug solubility, prolong circulation, facilitate cellular uptake, and enable tissue-specific or stimulus-responsive delivery. These characteristics have generated considerable interest in cancer therapy, infectious diseases, neurological disorders, cardiovascular diseases, inflammatory conditions, and nucleic-acid therapeutics. Recent research has also expanded the role of nanotechnology toward RNA delivery, immunotherapy, theranostics, biomimetic nanoparticles, and precision medicine. Nevertheless, substantial challenges remain, including nanoparticle toxicity, biological interactions, manufacturing complexity, reproducibility, pharmacokinetic uncertainty, regulatory requirements, and difficulties in translating promising laboratory findings into routine clinical practice. Recent reviews emphasize that although nanomedicine has demonstrated considerable therapeutic potential, clinical translation requires robust biological validation, scalable manufacturing, standardized characterization, and interdisciplinary collaboration. This paper examines the principles of nanotechnology-based drug delivery, major nanocarrier systems, mechanisms of targeted delivery, applications in modern medical treatment, emerging therapeutic strategies, challenges, ethical and safety considerations, and future directions.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
